GSK

Latest stories

15h
FOX Business
4 Safe Stocks With Dividend Yields Above 5%growth prospects lies in its newly found revenue diversity. After completing a
4 Safe Stocks With Dividend Yields Above 5%
FOX Business / Posted 15 hours ago
growth prospects lies in its newly found revenue diversity. After completing a three-part asset swap with Novartisin 2015, GSK now derives substantially more revenue from vaccines and a joint-venture in consumer healthcare with Novartis than before... Read more
4 related stories
15h
FOX Business
4 Safe Stocks With Dividend Yields Above 5%growth prospects lies in its newly found revenue diversity. After completing a
4 Safe Stocks With Dividend Yields Above 5%
FOX Business / Posted 15 hours ago
growth prospects lies in its newly found revenue diversity. After completing a three-part asset swap with Novartisin 2015, GSK now derives substantially more revenue from vaccines and a joint-venture in consumer healthcare with Novartis than before... Read more
4 related stories
16h
Business Standard India
Glenmark to ramp up respiratory business with new inhalerto introduce a new inhaler. We hope to launch it in six months," he added. Cip
Glenmark to ramp up respiratory business with new inhaler
Business Standard India / Posted 16 hours ago
to introduce a new inhaler. We hope to launch it in six months," he added. Cipla is a market leader in inhalation category in the domestic market. Other companies with significant presence in the segment include GSK Pharmaceuticals... Read more
1d
The Economic Times
TRACK SENSEX, NIFTY LIVE: Who moved my market today - The Economic Times& Toubro, Tata Steel, Bajaj Auto, GAIL Ashok Layland, Apollo Hospitals, Godrej
TRACK SENSEX, NIFTY LIVE: Who moved my market today - The Economic Times
The Economic Times / Posted yesterday
& Toubro, Tata Steel, Bajaj Auto, GAIL Ashok Layland, Apollo Hospitals, Godrej Industries, Ujjivan Financial Services, GSK Pharma, Essar Shipping, Usha Martin and VRL Logistics remained some of the BSE-listed companies that will disclose their... Read more
2 related stories
1d
Newsmax
COPD Drug Successful in Large Trialstudy that tested it in everyday use, providing a fillip for the product after
COPD Drug Successful in Large Trial
Newsmax / Posted yesterday
study that tested it in everyday use, providing a fillip for the product after the failure of another big trial in 2015. GSK said on Tuesday the study, which tested Breo in day-to-day practice across the town of Salford, showed it was superior in... Read more
1d
Robotics Online
The Business of Automation, Betting on Robotssuch as Shanghai SIASUN Robot & Automation, Dongguan Start To Sail Industrial R
The Business of Automation, Betting on Robots
Robotics Online / Posted yesterday
such as Shanghai SIASUN Robot & Automation, Dongguan Start To Sail Industrial Robots, Anhui Efort Intelligent Equipment, GSK CNC Equipment, Shanghai STEP Robot, and Estun Robotics. Frank Tobe, a long-time robotics industry analyst and... Read more
1d
Business Wire
Cell Medica Expands Management Team with Experienced Pharmaceutical Executivesstrategy for commercial supply of patient-specific cell products on a global le
Cell Medica Expands Management Team with Experienced Pharmaceutical Executives
Business Wire / Posted yesterday
strategy for commercial supply of patient-specific cell products on a global level. Through his previous positions at GSK Vaccines, Crucell, Merck Serono and Roche, Alain has extensive experience in product development and scaling... Read more
1d
Channel NewsAsia
GSK lung drug succeeds in big UK study, after earlier missstudy that tested it in everyday use, providing a fillip for the product after
GSK lung drug succeeds in big UK study, after earlier miss
Channel NewsAsia / Posted yesterday
study that tested it in everyday use, providing a fillip for the product after the failure of another big trial in 2015. GSK said on Tuesday that the study, which tested Breo in day-to-day practice across the town of Salford, showed it was... Read more
1d
The Economic Times
Baba Ramdev's Patanjali to now take on online healthcare startupsBaba Ramdev is taking on GlaxoSmithKline Consumer Healthcare, another world maj
Baba Ramdev's Patanjali to now take on online healthcare startups
The Economic Times / Posted yesterday
Baba Ramdev is taking on GlaxoSmithKline Consumer Healthcare, another world major in the health food drink (HFD) category. GSK Consumer, the maker of Horlicks, had announced a disappointing set of numbers for its JanuaryMarch (Q4FY16) quarter.That... Read more
2d
The Economic Times
After taking on global giants like Nestle, Baba Ramdev's Patanjali now targets HorlicksGSK Consumer, the maker of Horlicks , had announced a disappointing set of numb
After taking on global giants like Nestle, Baba Ramdev's Patanjali now targets Horlicks
The Economic Times / Posted 2 days ago
GSK Consumer, the maker of Horlicks , had announced a disappointing set of numbers for its January-March (Q4FY16) quarter. That resulted in at least three domestic brokerages expressing concern about the MNC major's ability to compete with Baba... Read more
2d
North-West Evening Mail
Kirkby United on brink of Furness Premier League title winBritannia edged a seven-goal thriller at Canal Foot as Liam Holmes and Ross Wal
Kirkby United on brink of Furness Premier League title win
North-West Evening Mail / Posted 2 days ago
Britannia edged a seven-goal thriller at Canal Foot as Liam Holmes and Ross Walker both scored twice in the 4-3 win over GSK Ulverston Rangers reserves. Josh Cronin, Peter Spence and Dan hall, with a free-kick from the halfway line, netted for... Read more
2d
The Financial Express
Hit by strike, GSK Consumer suspends ops at Punjab plantLast week, GlaxoSmithKline (GSK) Consumer Healthcare reported an 8.18 per cent
Hit by strike, GSK Consumer suspends ops at Punjab plant
The Financial Express / Posted 2 days ago
Last week, GlaxoSmithKline (GSK) Consumer Healthcare reported an 8.18 per cent decline in its stand-alone net profit for the March quarter at Rs 180.7 crore. (Reuters) GlaxoSmithKline Consumer Healthcare has suspended operations temporarily at its... Read more
7 related stories
2d
The Economic Times
Hit by strike, GSK Consumer suspends ops at Punjab plantoperations temporarily at its factory located at Nabha Patiala - 147201 with ef
Hit by strike, GSK Consumer suspends ops at Punjab plant
The Economic Times / Posted 2 days ago
operations temporarily at its factory located at Nabha Patiala - 147201 with effect from the night of May 21, 2016," GSK Consumer Healthcare said in a BSE filing today. The company added that it took the step "in the interest of safety and... Read more
7 related stories
3d
New Kerala
Derivatives expiry, results to guide equity markets (Market Outlook) - newkerala.com #67068Corporation, Bajaj Auto, Ashok Leyland, Tata Steel, GAIL, India Cements, BHEL,
Derivatives expiry, results to guide equity markets (Market Outlook) - newkerala.com #67068
New Kerala / Posted 3 days ago
Corporation, Bajaj Auto, Ashok Leyland, Tata Steel, GAIL, India Cements, BHEL, Crompton Greaves, Cipla, Abbott India, GSK Pharma are expected to announce their Q4 results in the coming week. "Investors will closely track the next batch of Q4... Read more
4d
Business Standard India
Tanoubi Ngangom: Navigating the IPR mazeof drug-wise data conducted by Medecins Sans Frontieres (MSF) shows that Aspen
Tanoubi Ngangom: Navigating the IPR maze
Business Standard India / Posted 4 days ago
of drug-wise data conducted by Medecins Sans Frontieres (MSF) shows that Aspen Pharma care under a VL with GlaxoSmithKline (GSK) markets a second-line ARV medication at $69 per patient per year. Other generics companies sell the same drug at much... Read more
5d
Channel NewsAsia
China slashes GSK, AstraZeneca drug prices in cost-cutting driveprices of some medicines used to treat serious diseases, including cancer, but
China slashes GSK, AstraZeneca drug prices in cost-cutting drive
Channel NewsAsia / Posted 5 days ago
prices of some medicines used to treat serious diseases, including cancer, but had not named the drugs involved. Britain's GSK, which has struggled to rebuild sales in China following a damaging bribery scandal that landed it with a record fine in... Read more
5d
North-West Evening Mail
Zach at the double as Hawcoat lift Terry Clinton Memorial cupat Askam United tomorrow, at Holker Old Boys on Monday and the return with Cava
Zach at the double as Hawcoat lift Terry Clinton Memorial cup
North-West Evening Mail / Posted 5 days ago
at Askam United tomorrow, at Holker Old Boys on Monday and the return with Cavaliers on Wednesday before finishing at GSK Ulverston Rangers. Holker reserves have had a busy week, beating Swarthmoor Social reserves 8-2 on Monday and drawing... Read more
6d
The Courier
Superbugs will kill 10 million people a year by 2050a pledge to increase investment on research into new antibiotics and vaccines.
Superbugs will kill 10 million people a year by 2050
The Courier / Posted 6 days ago
a pledge to increase investment on research into new antibiotics and vaccines. In a statement in response to the review, GSK chief executive Sir Andrew Witty said it was a "helpful step" and government and industry needed to work together to... Read more
92 related stories
6d
West Moreland Gazette
Record figures for Low Wood No Wood cardboard boat racebe honoured were: • Progression prize for the best youth team – ‘The Unsinkabl
Record figures for Low Wood No Wood cardboard boat race
West Moreland Gazette / Posted 6 days ago
be honoured were: • Progression prize for the best youth team – ‘The Unsinkables’ • Best boat design – ‘HMS Zinacef’ from GSK Ulverston • Best dressed, themed team or paddler – Billy Ellis and his boat ‘Coconut Island #1’ • Titanic award for... Read more
7d
WA Today
Worse than cancer: superbugs will kill 10 million people a year by 2050a pledge to increase investment on research into new antibiotics and vaccines.
Worse than cancer: superbugs will kill 10 million people a year by 2050
WA Today / Posted 7 days ago
a pledge to increase investment on research into new antibiotics and vaccines. In a statement in response to the review, GSK chief executive Sir Andrew Witty said it was a "helpful step" and government and industry needed to work together to... Read more
92 related stories
7d
Canberra Times
Worse than cancer: superbugs will kill 10 million people a year by 2050a pledge to increase investment on research into new antibiotics and vaccines.
Worse than cancer: superbugs will kill 10 million people a year by 2050
Canberra Times / Posted 7 days ago
a pledge to increase investment on research into new antibiotics and vaccines. In a statement in response to the review, GSK chief executive Sir Andrew Witty said it was a "helpful step" and government and industry needed to work together to... Read more
92 related stories
7d
The Border Mail
Superbugs will kill 10 million people a year by 2050a pledge to increase investment on research into new antibiotics and vaccines.
Superbugs will kill 10 million people a year by 2050
The Border Mail / Posted 7 days ago
a pledge to increase investment on research into new antibiotics and vaccines. In a statement in response to the review, GSK chief executive Sir Andrew Witty said it was a "helpful step" and government and industry needed to work together to... Read more
92 related stories
7d
Illawarra Mercury
Superbugs will kill 10 million people a year by 2050a pledge to increase investment on research into new antibiotics and vaccines.
Superbugs will kill 10 million people a year by 2050
Illawarra Mercury / Posted 7 days ago
a pledge to increase investment on research into new antibiotics and vaccines. In a statement in response to the review, GSK chief executive Sir Andrew Witty said it was a "helpful step" and government and industry needed to work together to... Read more
92 related stories
7d
The Courier
Superbugs will kill 10 million people a year by 2050a pledge to increase investment on research into new antibiotics and vaccines.
Superbugs will kill 10 million people a year by 2050
The Courier / Posted 7 days ago
a pledge to increase investment on research into new antibiotics and vaccines. In a statement in response to the review, GSK chief executive Sir Andrew Witty said it was a "helpful step" and government and industry needed to work together to... Read more
92 related stories
7d
Northern Daily Leader
Superbugs will kill 10 million people a year by 2050a pledge to increase investment on research into new antibiotics and vaccines.
Superbugs will kill 10 million people a year by 2050
Northern Daily Leader / Posted 7 days ago
a pledge to increase investment on research into new antibiotics and vaccines. In a statement in response to the review, GSK chief executive Sir Andrew Witty said it was a "helpful step" and government and industry needed to work together to... Read more
92 related stories
7d
The Young Witness
Superbugs will kill 10 million people a year by 2050a pledge to increase investment on research into new antibiotics and vaccines.
Superbugs will kill 10 million people a year by 2050
The Young Witness / Posted 7 days ago
a pledge to increase investment on research into new antibiotics and vaccines. In a statement in response to the review, GSK chief executive Sir Andrew Witty said it was a "helpful step" and government and industry needed to work together to... Read more
92 related stories
7d
Western Advocate
Superbugs will kill 10 million people a year by 2050a pledge to increase investment on research into new antibiotics and vaccines.
Superbugs will kill 10 million people a year by 2050
Western Advocate / Posted 7 days ago
a pledge to increase investment on research into new antibiotics and vaccines. In a statement in response to the review, GSK chief executive Sir Andrew Witty said it was a "helpful step" and government and industry needed to work together to... Read more
92 related stories
7d
Kiama Independent
Superbugs will kill 10 million people a year by 2050a pledge to increase investment on research into new antibiotics and vaccines.
Superbugs will kill 10 million people a year by 2050
Kiama Independent / Posted 7 days ago
a pledge to increase investment on research into new antibiotics and vaccines. In a statement in response to the review, GSK chief executive Sir Andrew Witty said it was a "helpful step" and government and industry needed to work together to... Read more
92 related stories
7d
Manning River Times
Superbugs will kill 10 million people a year by 2050a pledge to increase investment on research into new antibiotics and vaccines.
Superbugs will kill 10 million people a year by 2050
Manning River Times / Posted 7 days ago
a pledge to increase investment on research into new antibiotics and vaccines. In a statement in response to the review, GSK chief executive Sir Andrew Witty said it was a "helpful step" and government and industry needed to work together to... Read more
92 related stories
7d
Goondiwindi Argus
Superbugs will kill 10 million people a year by 2050a pledge to increase investment on research into new antibiotics and vaccines.
Superbugs will kill 10 million people a year by 2050
Goondiwindi Argus / Posted 7 days ago
a pledge to increase investment on research into new antibiotics and vaccines. In a statement in response to the review, GSK chief executive Sir Andrew Witty said it was a "helpful step" and government and industry needed to work together to... Read more
92 related stories
7d
The North West Star
Superbugs will kill 10 million people a year by 2050a pledge to increase investment on research into new antibiotics and vaccines.
Superbugs will kill 10 million people a year by 2050
The North West Star / Posted 7 days ago
a pledge to increase investment on research into new antibiotics and vaccines. In a statement in response to the review, GSK chief executive Sir Andrew Witty said it was a "helpful step" and government and industry needed to work together to... Read more
92 related stories
7d
Brisbane Times
Worse than cancer: superbugs will kill 10 million people a year by 2050a pledge to increase investment on research into new antibiotics and vaccines.
Worse than cancer: superbugs will kill 10 million people a year by 2050
Brisbane Times / Posted 7 days ago
a pledge to increase investment on research into new antibiotics and vaccines. In a statement in response to the review, GSK chief executive Sir Andrew Witty said it was a "helpful step" and government and industry needed to work together to... Read more
92 related stories
7d
Daily Liberal
Superbugs will kill 10 million people a year by 2050a pledge to increase investment on research into new antibiotics and vaccines.
Superbugs will kill 10 million people a year by 2050
Daily Liberal / Posted 7 days ago
a pledge to increase investment on research into new antibiotics and vaccines. In a statement in response to the review, GSK chief executive Sir Andrew Witty said it was a "helpful step" and government and industry needed to work together to... Read more
92 related stories
7d
The Age
Worse than cancer: superbugs will kill 10 million people a year by 2050a pledge to increase investment on research into new antibiotics and vaccines.
Worse than cancer: superbugs will kill 10 million people a year by 2050
The Age / Posted 7 days ago
a pledge to increase investment on research into new antibiotics and vaccines. In a statement in response to the review, GSK chief executive Sir Andrew Witty said it was a "helpful step" and government and industry needed to work together to... Read more
92 related stories
7d
Sydney Morning Herald
Worse than cancer: superbugs will kill 10 million people a year by 2050a pledge to increase investment on research into new antibiotics and vaccines.
Worse than cancer: superbugs will kill 10 million people a year by 2050
Sydney Morning Herald / Posted 7 days ago
a pledge to increase investment on research into new antibiotics and vaccines. In a statement in response to the review, GSK chief executive Sir Andrew Witty said it was a "helpful step" and government and industry needed to work together to... Read more
92 related stories
7d
Business Standard India
GSK Consumer valuation unsustainablewith phasing out of fiscal benefits, at its Baddi plant in Himachal Pradesh hur
GSK Consumer valuation unsustainable
Business Standard India / Posted 7 days ago
with phasing out of fiscal benefits, at its Baddi plant in Himachal Pradesh hurt GlaxoSmithKline Consumer Healthcare (GSK Consumer)’s volumes in the quarter ended March. While the company hasn't shared volume details, analysts estimate it to... Read more
7d
Business Standard India
GSK Consumer: Rich valuations unsustainable amid slowing volumesRevenues declined in March quarter while increased competition led to higher ad
GSK Consumer: Rich valuations unsustainable amid slowing volumes
Business Standard India / Posted 7 days ago
Revenues declined in March quarter while increased competition led to higher ad-spends and impacted While GSK Consumer has not shared the volume details, analysts estimate it to have... Read more
7d
The Economic Times
Smallcaps rule the roost; PNB shrugs off record-breaking quarterly lossof Rs.231 crore, compared with Rs 138 crore profits it reported the in correspo
Smallcaps rule the roost; PNB shrugs off record-breaking quarterly loss
The Economic Times / Posted 7 days ago
of Rs.231 crore, compared with Rs 138 crore profits it reported the in corresponding quarter of last year. Live charts hereGSK Consumer down on weak Q4 report card: Shares of GSK Consumer Healthcare slumped 3.87 per cent to Rs 5,850.20 after the... Read more
7d
walesonline
Richard Parks says he was a 'ticking time bomb' on Everestthe data we collected on the mountain. It has highlighted some really interesti
Richard Parks says he was a 'ticking time bomb' on Everest
walesonline / Posted 7 days ago
the data we collected on the mountain. It has highlighted some really interesting findings. “The guys at USW and also at GSK [GlaxoSmithKline] have got a really busy six months to analyse that data, and that in itself is still groundbreaking it... Read more
7d
Business Wire
Bellicum Appoints Jim Daly to its Board of DirectorsNplate®, Xgeva® and Prolia®. Earlier in his career, Mr. Daly spent over 16 yea
Bellicum Appoints Jim Daly to its Board of Directors
Business Wire / Posted 7 days ago
Nplate®, Xgeva® and Prolia®. Earlier in his career, Mr. Daly spent over 16 years with Glaxo Wellcome/GlaxoSmithKline (GSK) where he held roles of increasing responsibility, including Senior Vice President, General Manager, Respiratory and... Read more
7d
Business Standard India
Markets pose smart recovery in late trades; Nifty ends above 7,850concluded its extended initial public offering (IPO), will list shares on the b
Markets pose smart recovery in late trades; Nifty ends above 7,850
Business Standard India / Posted 7 days ago
concluded its extended initial public offering (IPO), will list shares on the bourses tomorrow. Shares of GlaxoSmithKline (GSK) Consumer Healthcare fell 3.6% today after the company reported an 8.18% decline in standalone net profit for the March... Read more
143 related stories
7d
Business Standard India
GSK Consumer Healthcare slips after weak Q4 earningsShares of GlaxoSmithKline (GSK) Consumer Healthcare fell over 5% today after th
GSK Consumer Healthcare slips after weak Q4 earnings
Business Standard India / Posted 7 days ago
Shares of GlaxoSmithKline (GSK) Consumer Healthcare fell over 5% today after the company reported an 8.18% decline in standalone net profit for the March quarter at Rs 180.68 crore. Net sales during the period under review was Rs 1,052.83 crore,... Read more
5 related stories
8d
Business Standard India
Weak global cues take shine off markets; Sensex dips 200 pointsin automobile industry, aerospace industry and for domestic panels.However, the
Weak global cues take shine off markets; Sensex dips 200 points
Business Standard India / Posted 8 days ago
in automobile industry, aerospace industry and for domestic panels.However, the stock is down 0.35. Consumer goods major GSK Consumer Health care has slumped over 4% after it posted Rs 181 crore net profit during the quarter ended March 31,... Read more
8d
Business Standard India
Weak global peers may push markets lower; 10 stocks in focusfor making structures for use in automobile industry, aerospace industry and fo
Weak global peers may push markets lower; 10 stocks in focus
Business Standard India / Posted 8 days ago
for making structures for use in automobile industry, aerospace industry and for domestic panels. Consumer goods major GSK Consumer Health care posted Rs 181 crore net profit during the quarter ended March 31, compared to Rs 197 crore during... Read more
143 related stories
8d
The Economic Times
Fifteen stocks in focus in Wednesday morning tradeThe scheme of amalgamation between was earlier sanctioned by the Bombay High Co
Fifteen stocks in focus in Wednesday morning trade
The Economic Times / Posted 8 days ago
The scheme of amalgamation between was earlier sanctioned by the Bombay High Court on August 21, 2015. GlaxoSmithKline (GSK) Consumer Healthcare Ltd: The pharma company on Tuesday reported an 8.18 per cent decline in its standalone net profit... Read more
8d
The Comet
Mum of Stotfold boy severely disabled by meningitis says financial gain over vaccine is ‘disgusting’that trauma will not be comforted by the fact that from 2017 we will have a bet
Mum of Stotfold boy severely disabled by meningitis says financial gain over vaccine is ‘disgusting’
The Comet / Posted 8 days ago
that trauma will not be comforted by the fact that from 2017 we will have a better idea of what to do.” A spokesman for GSK said: “The Government has a well-established, effective vaccines procurement process to ensure vaccination programmes are... Read more
9d
The Economic Times
TRACK SENSEX, NIFTY LIVE: Who moved my market today - The Economic Timeswill react to the earnings of Motherson Sumi, United Bank, Syndicate Bank, Volt
TRACK SENSEX, NIFTY LIVE: Who moved my market today - The Economic Times
The Economic Times / Posted 9 days ago
will react to the earnings of Motherson Sumi, United Bank, Syndicate Bank, Voltas, Mahindra Holidays, Gujarat Gas and GSK Consumer Healthcare, among others, today. @9.06 AM: Stocks to watch today:Pfizer will acquire Anacor Pharmaceuticals in... Read more
9 related stories
9d
Business Standard India
Firm global cues likely to perk up marketscompany to take up the revival of fertiliser plants of Fertiliser Corporation o
Firm global cues likely to perk up markets
Business Standard India / Posted 9 days ago
company to take up the revival of fertiliser plants of Fertiliser Corporation of India at select locations. Motherson Sumi, Bharat Forge, Voltas and GSK Consumer Healthcare will react to their March quarter earnings scheduled for release later tod... Read more
9d
The Irish Times
Friday 13th was a lucky day for family-run AE Globaland in particular Derry? The firm specialises in mechanical and electrical eng
Friday 13th was a lucky day for family-run AE Global
The Irish Times / Posted 9 days ago
and in particular Derry? The firm specialises in mechanical and electrical engineering and clients include the likes of GSK (GlaxoSmithKline), BP, Dupont and Seagate. It was originally set up by two Derry entrepreneurs in 1994 and the reason... Read more
9d
Scotsman
Fresh calls for roll-out of meningitis vaccine in Scotlandthe start of the year, apart from the NHS programme for newborns which was ring
Fresh calls for roll-out of meningitis vaccine in Scotland
Scotsman / Posted 9 days ago
the start of the year, apart from the NHS programme for newborns which was ring-fenced. A spokeswoman for GlaxoSmithKline (GSK), which is the only company that manufactures the drug, confirmed new stocks would be available from the start of... Read more
22 related stories
More

People in this news